Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivar Roots

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Pharmacogenetics and Genomics|October 13, 2005
St. John's wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathwaysSolveigh Krusekopf, Ivar Roots
Biochemical and Biophysical Research Communications|April 3, 2003
In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1Dieter Schwarz, Ivar Roots
Pharmazie in Unserer Zeit|June 6, 2003
[Adverse drug effects and interactions. What is the current thinking about the use of St. John's wort?]Andreas Johne, Ivar Roots
Pharmacogenetics and Genomics|November 17, 2006
In-vitro transport characteristics discriminate wild-type ABCB1 (MDR1) from ALA893SER and ALA893THR polymorphismsMelanie Schaefer, Ivar Roots, Thomas Gerloff
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2003
A single nucleotide polymorphism in the human H-ras proto-oncogene determines the risk of urinary bladder cancerAndreas Johne, Ivar Roots, Jürgen Brockmöller
Atherosclerosis|June 24, 2003
Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofenChristian Meisel, Andreas Johne, Ivar Roots
Cancer Research|November 25, 2003
St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1Dieter Schwarz, Pyotr Kisselev, Ivar Roots
The New England Journal of Medicine|January 31, 2003
Polymorphisms of adrenergic receptors and the risk of heart failureChristian Meisel, Karla Köpke, Ivar Roots
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetinDieter Schwarz, Pyotr Kisselev, Ivar Roots
European Journal of Pharmacology|April 8, 2003
Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43Solveigh Krusekopf, Ivar Roots, Ullrich Kleeberg
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Pharmacogenetics and Genomics|October 13, 2005
St. John's wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathwaysSolveigh Krusekopf, Ivar Roots
Biochemical and Biophysical Research Communications|April 3, 2003
In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1Dieter Schwarz, Ivar Roots
Pharmazie in Unserer Zeit|June 6, 2003
[Adverse drug effects and interactions. What is the current thinking about the use of St. John's wort?]Andreas Johne, Ivar Roots
Pharmacogenetics and Genomics|November 17, 2006
In-vitro transport characteristics discriminate wild-type ABCB1 (MDR1) from ALA893SER and ALA893THR polymorphismsMelanie Schaefer, Ivar Roots, Thomas Gerloff
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2003
A single nucleotide polymorphism in the human H-ras proto-oncogene determines the risk of urinary bladder cancerAndreas Johne, Ivar Roots, Jürgen Brockmöller
Atherosclerosis|June 24, 2003
Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofenChristian Meisel, Andreas Johne, Ivar Roots
Cancer Research|November 25, 2003
St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1Dieter Schwarz, Pyotr Kisselev, Ivar Roots
The New England Journal of Medicine|January 31, 2003
Polymorphisms of adrenergic receptors and the risk of heart failureChristian Meisel, Karla Köpke, Ivar Roots
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetinDieter Schwarz, Pyotr Kisselev, Ivar Roots
European Journal of Pharmacology|April 8, 2003
Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43Solveigh Krusekopf, Ivar Roots, Ullrich Kleeberg
Pageof 10